BIOX vs EVGN: stock comparison and AI forecast
Bioceres Crop Solutions Corp. (BIOX) and Evogene Ltd. (EVGN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BIOX Bioceres Crop Solutions Corp.
- Market Cap
- $15M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
EVGN Evogene Ltd.
- Market Cap
- $5M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- BIOX is 3.0 times larger than EVGN by market capitalization ($15M against $5M).
- Both companies share the SEC industry classification Agricultural Chemicals.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BIOX | EVGN |
|---|---|---|
| Market Cap | $15M | $5M |
| EPS | $-3.02 | $-4.15 |
| Revenue/Share | $4.99 | $1.52 |
| FCF/Share | $0.92 | $-4.33 |
Profitability & Margins
| Metric | BIOX | EVGN |
|---|---|---|
| ROA | – | -290.0% |
| ROIC | 10.2% | – |
| Gross Margin | 41.4% | 59.7% |
| Operating Margin | 7.4% | -315.6% |
| Net Margin | – | -251.6% |
| EBT Margin | -3.7% | -291.5% |
| Tax Rate | -8.3% | 0.0% |
Financial Health
| Metric | BIOX | EVGN |
|---|---|---|
| Current Ratio | 0.90x | 4.54x |
| Quick Ratio | 0.70x | 4.48x |
| D/E Ratio | 5.94x | – |
| Financial Leverage | 7.33x | – |
| Working Capital | -$34M | $12M |
Cash Flow
| Metric | BIOX | EVGN |
|---|---|---|
| Operating Cash Flow | $69M | -$64M |
| Free Cash Flow | $59M | -$66M |
| Capital Spending | -$10M | -$2M |
| OCF Growth YoY | -6.9% | – |
| FCF Growth YoY | 0.0% | – |
| FCF/Sales | 18.4% | -285.9% |
| CapEx/Sales | 3.3% | 7.4% |
Operational Efficiency
| Metric | BIOX | EVGN |
|---|---|---|
| Asset Turnover | 0.57x | 1.15x |
| Inventory Turnover | 2.9x | 44.4x |
| Fixed Assets Turnover | 5.2x | 28.5x |
| Days Inventory | 127 days | 8 days |
| Payables Period | 175 days | 25 days |
Income Statement
| Metric | BIOX | EVGN |
|---|---|---|
| Total Revenue | $319M | $23M |
| Operating Income | $24M | -$73M |
| Net Income | – | -$58M |
| R&D Expense | $16M | $54M |
| SG&A Expense | $100M | $21M |
| Cost of Goods Sold | $187M | $9M |
Dividend & Shareholder Information
| Metric | BIOX | EVGN |
|---|---|---|
| Shares Outstanding | 64M | 15M |
BIOX vs EVGN: stock comparison and AI forecast
Which is bigger, BIOX or EVGN?
BIOX is 3.0 times larger than EVGN by market capitalization ($15M against $5M).
Which one does Intratio's AI model rank higher, BIOX or EVGN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.